Creative Financial Designs’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
AAP
SWP
FIA
SH
Creative Financial Designs's GNOM Position: Q2 2026 in Review
Creative Financial Designs increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 13% in Q2 2026, buying an estimated $63.5K and bringing the position to 11,892 shares worth $676K. The position accounts for 0.03% of the portfolio, ranked #345.
Creative Financial Designs first reported a position in GNOM in Q3 2021 and has held it in 18 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- Creative Financial Designs held 11,892 shares of Global X Genomics & Biotechnology ETF worth $676K as of Q2 2026.
- Creative Financial Designs bought 1,332 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $63.5K.
- Global X Genomics & Biotechnology ETF made up 0.03% of Creative Financial Designs's portfolio in Q2 2026, its #345 holding.
- Creative Financial Designs first reported a position in Global X Genomics & Biotechnology ETF in Q3 2021 and has held it in 18 quarters since.
- 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.